AccuStem Sciences, Inc.
ACUT
$0.16
-$0.07-28.89%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.18% | -26.97% | -16.68% | -17.03% | 6.50% |
| Total Depreciation and Amortization | -100.00% | -96.67% | -88.89% | -63.89% | -38.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.15% | -77.56% | -44.73% | 460.03% | 444.65% |
| Change in Net Operating Assets | -42.89% | 146.78% | 38.13% | -0.43% | 37.72% |
| Cash from Operations | -147.85% | -30.33% | -28.04% | 9.09% | 55.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 120.84% | 18.63% | 22.52% | -11.98% | -53.90% |
| Total Debt Repaid | 13.51% | 8.24% | 26.76% | 33.60% | 54.73% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 151.64% | 22.35% | 32.67% | -8.20% | -53.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.85% | -189.63% | 153.66% | 33.04% | 80.27% |